Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Prediction of MS disability by multimodal evoked potentials: Investigation during relapse or in the relapse-free interval?
Comparing statistical methods for removing seasonal variation from vitamin D measurements in case-control studies.
Serial magnetic resonance imaging representation in a Baló's concentric sclerosis.
Promoting peripheral myelin repair.
Efficacy of gabapentin in the treatment of SUNCT syndrome.
Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis.
Dendritic cells as therapeutic targets in neuroinflammation.
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice.
The Role of Astrocytes in Multiple Sclerosis Progression.
The signal intensity ratio of the optic nerve to ipsilateral frontal white matter is of value in the diagnosis of acute optic neuritis.
Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study.
NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis.
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study.
Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
KV1 channels identified in rodent myelinated axons, linked to Cx29 in innermost myelin: Support for electrically-active myelin in mammalian saltatory conduction.
Why some of us do not like the expression "no evidence of disease activity" (NEDA) in multiple sclerosis.
Erratum to: Reassessing the risk of natalizumab-associated PML.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).
Home or away? Choosing a setting for a falls-prevention program for people with multiple sclerosis.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.
Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: The impact of thalamic subnuclei on disability.
Pages
« first
‹ previous
…
647
648
649
650
651
652
653
654
655
…
next ›
last »